This article has been updated with additional comment from the company's earnings conference call.

NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Tuesday that its second quarter revenues dropped 42 percent year over year.

For the three months ended June 30, the firm reported total revenues of $703,210, down from $1.2 million in Q2 2016. Product sales fell to $681,127 from $1.0 million in the year-ago quarter, while lab services revenues fell to $15,850 from $29,674, and collaboration revenues sank to $6,233 from $125,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.